Ameritas Investment Partners’s MaxCyte MXCT Stock Holding History

Ameritas Investment Partners’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.2K	Hold	10,250	–	–	﹤0.01%	2928
2025 Q4	$15.9K	Hold	10,250	–	–	﹤0.01%	2747
2025 Q3	$16.2K	Hold	10,250	–	–	﹤0.01%	2763
2025 Q2	$22.3K	Hold	10,250	–	–	﹤0.01%	2607
2025 Q1	$28K	Hold	10,250	–	–	﹤0.01%	2406
2024 Q4	$42.6K	Hold	10,250	–	–	﹤0.01%	2279
2024 Q3	$39.9K	Hold	10,250	–	–	﹤0.01%	2325
2024 Q2	$40.2K	Buy	10,250 +2,833	+38%	+$12.2K	﹤0.01%	2261
2024 Q1	$31.1K	Hold	7,417	–	–	﹤0.01%	2386
2023 Q4	$34.9K	Hold	7,417	–	–	﹤0.01%	2340
2023 Q3	$23.1K	Hold	7,417	–	–	﹤0.01%	2476
2023 Q2	$34K	Hold	7,417	–	–	﹤0.01%	2272
2023 Q1	$36.7K	Hold	7,417	–	–	﹤0.01%	2164
2022 Q4	$40.6K	Hold	7,417	–	–	﹤0.01%	2204
2022 Q3	$48K	Hold	7,417	–	–	﹤0.01%	2005
2022 Q2	$35K	Hold	7,417	–	–	﹤0.01%	2223
2022 Q1	$52K	Hold	7,417	–	–	﹤0.01%	2046
2021 Q4	$76K	Buy	7,417 +6,216	+518%	+$66.8K	﹤0.01%	1853
2021 Q3	$15K	Buy	+1,201	New	+$18.1K	﹤0.01%	2821

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Ameritas Investment Partners's MXCT Position: Q1 2026 in Review

Ameritas Investment Partners held its MaxCyte (MXCT) position steady in Q1 2026 at 10,250 shares worth $7.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Ameritas Investment Partners first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $76K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Ameritas Investment Partners held 10,250 shares of MaxCyte worth $7.2K as of Q1 2026.
Ameritas Investment Partners left its MaxCyte share count unchanged in Q1 2026.
MaxCyte made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2928 holding.
Ameritas Investment Partners first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
Ameritas Investment Partners's MaxCyte position peaked at $76K in Q4 2021.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.